Hot Pursuit     11-Jul-22
Biocon Ltd spurts 1.61%, up for five straight sessions
Biocon Ltd is quoting at Rs 328, up 1.61% on the day as on 12:44 IST on the NSE. The stock is down 15.32% in last one year as compared to a 2.83% jump in NIFTY and a 13.05% jump in the Nifty Metal.

Biocon Ltd is up for a fifth straight session today. The stock is quoting at Rs 328, up 1.61% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.52% on the day, quoting at 16136.85. The Sensex is at 54178.79, down 0.56%. Biocon Ltd has slipped around 0.92% in last one month.

Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has slipped around 2.5% in last one month and is currently quoting at 12449.45, up 0.38% on the day. The volume in the stock stood at 6.38 lakh shares today, compared to the daily average of 18.7 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 329.35, up 1.73% on the day. Biocon Ltd is down 15.32% in last one year as compared to a 2.83% jump in NIFTY and a 13.05% jump in the Nifty Metal index.

The PE of the stock is 467.61 based on TTM earnings ending March 22.

Previous News
  Biocon
 ( Results - Analysis 09-May-25   10:36 )
  Biocon to hold AGM
 ( Corporate News - 09-May-25   09:23 )
  Board of Biocon recommends final dividend
 ( Corporate News - 09-May-25   09:23 )
  Biocon consolidated net profit rises 154.24% in the March 2025 quarter
 ( Results - Announcements 09-May-25   07:38 )
  Biocon edges higher after biologics arm secures multiple market access deals for Yesintek
 ( Hot Pursuit - 05-May-25   09:31 )
  Biocon’s board OKs to raise Rs 4,500-cr
 ( Hot Pursuit - 24-Apr-25   08:11 )
  Board of Biocon approves fund raising up to Rs 4,500 cr
 ( Corporate News - 23-Apr-25   20:05 )
  Biocon to consider fund Raising
 ( Corporate News - 21-Apr-25   09:37 )
  Biocon surges on U.S. deal for Eylea copycat drug
 ( Hot Pursuit - 15-Apr-25   09:58 )
  Biocon Biologics inks a settlement and license agreement with Regeneron
 ( Corporate News - 15-Apr-25   09:29 )
  Biocon Biologics receives USFDA approval for Jobevne™ (Biosimilar Bevacizumab)
 ( Corporate News - 10-Apr-25   13:25 )
Other Stories
  Birla Corporation Ltd leads gainers in 'A' group
  12-May-25   12:00
  Navin Fluorine Intl Q4 PAT rises 35% YoY to Rs 95 cr; declares dividend of Rs 7/sh
  12-May-25   11:58
  Manappuram Finance rises on appointing Deepak Reddy as CEO
  12-May-25   11:45
  Borosil Renewables edges higher after net loss falls sharply in Q4
  12-May-25   11:41
  K.P.R. Mill slides after Q4 PAT drops 4% YoY to Rs 204 cr
  12-May-25   11:33
  Reliance Power soars after subsidiary bags SJVN solar project
  12-May-25   11:33
  Triveni Turbine zooms as Q4 PAT jumps 24% YoY to Rs 95 cr
  12-May-25   11:13
  BSE SME Srigee DLM ignites on listing day
  12-May-25   11:01
  Volumes spurt at Birla Corporation Ltd counter
  12-May-25   11:00
  BSE SME Manoj Jewellers' debut lacks luster
  12-May-25   10:51
Back Top